Keyword: Howard Hughes Medical Institute
Harnessing macrophages that provide healing in response to inflammation could be a better approach to treating heart attack than stem cells have been.
In a first, a 15-year-old cystic fibrosis patient with an antibiotic-resistant infection was successfully treated with gene-edited phages.
The ion channel-based chemogenetic platform involves pairing cell surface proteins with Chantix to selectively control neuronal activities.
A mouse study shed light on the mechanism that causes an inherited form of deafness, as well as a potential treatment.
Scientists are looking to deploy CRISPR in genetic deafness—and they have their first evidence that their technique may hold promise.
The past week ushered in discoveries related to high cholesterol, acute myeloid leukemia and age-related memory loss.